期刊
JOURNAL OF HEART AND LUNG TRANSPLANTATION
卷 35, 期 12, 页码 1385-1398出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.healun.2016.10.005
关键词
lung transplantation; extracorporeal membrane oxygenation; mechanical ventilation; end-stage lung disease; artificial organ support
资金
- International Society for Heart and Lung Transplantation
- Deutsche Forschungsgemeinschaft
- German Center of Lung Research (DZL)
- Actelion Pharmaceuticals
- Bayer
- Gilead
- GSK
- MSD
- Pfizer
Lung transplantation increasingly is being performed in recipients of higher risk and acuity. A subset of these patients has severely abnormal gas exchange and/or right ventricular dysfunction, such that artificial organ support strategies are required to bridge patients to lung transplantation. We review the rationales and currently used and potential strategies for bridging to lung transplantation and characterize bridging outcomes. Based on physiologic reasoning and a study of the existing literature, we provide a working strategy for bridging to lung transplantation. (C) 2016 International Society for Heart and Lung Transplantation. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据